GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln
BY Asian Legal Business《亚洲法律杂志》 |
Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.